Description :
Xeloda contains Capecitabine, an oral chemotherapy medication used in the treatment of various cancers, including breast cancer, colorectal cancer, and gastric cancer. It is a prodrug that is converted in the body to 5-fluorouracil (5-FU), which works by interfering with DNA synthesis in cancer cells, thereby slowing or stopping their growth.
Dosage (General Use):
The typical dose is 1,250 mg/m² twice daily (morning and evening) for 14 days, followed by a 7-day rest period (one cycle = 21 days).
Dosage depends on the patient’s body surface area, cancer type, and response to treatment.
Swallow tablets whole with water within 30 minutes after a meal.
(Exact dosing must be determined by an oncologist.)
Precautions & Warnings:
Not suitable for patients with severe kidney or liver impairment.
Use with caution in patients with heart disease, infections, or low blood counts.
May interact with anticoagulants (e.g., warfarin), phenytoin, and folinic acid.
Pregnancy and breastfeeding are not recommended during treatment.
Regular blood tests are required to monitor liver, kidney function, and blood counts.
Possible Side Effects:
Common: Nausea, vomiting, diarrhea, abdominal pain, fatigue, loss of appetite.
Hand-foot syndrome (redness, swelling, pain in palms/soles).
Mouth sores, dry skin, or rash.
Serious: Severe diarrhea, bleeding, chest pain, jaundice, or infection signs.
